These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


527 related items for PubMed ID: 15826485

  • 1. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F.
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [Abstract] [Full Text] [Related]

  • 2. Steatosis and hepatocellular carcinoma risk.
    Smedile A, Bugianesi E.
    Eur Rev Med Pharmacol Sci; 2005 Mar; 9(5):291-3. PubMed ID: 16231592
    [Abstract] [Full Text] [Related]

  • 3. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, Kurokawa F, Maeyama S, Okita K.
    J Gastroenterol; 2004 Mar; 39(4):391-6. PubMed ID: 15168253
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H, Suzuki M, Takahashi H, Kobayashi M, Okuse N, Moriya H, Koike J, Maeyama S, Yotsuyanagi H, Itoh F.
    Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679
    [Abstract] [Full Text] [Related]

  • 5. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH.
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [Abstract] [Full Text] [Related]

  • 6. NASH and HCC.
    Page JM, Harrison SA.
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [Abstract] [Full Text] [Related]

  • 7. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
    Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, Degos F, Farges O, Belghiti J.
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
    [Abstract] [Full Text] [Related]

  • 8. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [Abstract] [Full Text] [Related]

  • 9. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ.
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [Abstract] [Full Text] [Related]

  • 10. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
    Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, Teramoto K, Igari T, Arii S.
    Hepatogastroenterology; 2008 Aug; 55(82-83):609-14. PubMed ID: 18613418
    [Abstract] [Full Text] [Related]

  • 11. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H, Ohyama R, Tsuka N, Eyden BP, Yamazaki K.
    J Submicrosc Cytol Pathol; 2001 Aug; 33(1-2):195-200. PubMed ID: 11686402
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 13. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
    Sorrentino P, D'Angelo S, Ferbo U, Micheli P, Bracigliano A, Vecchione R.
    J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
    [Abstract] [Full Text] [Related]

  • 14. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L, Lemoine M.
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [Abstract] [Full Text] [Related]

  • 15. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S, Mori M.
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [Abstract] [Full Text] [Related]

  • 16. Natural history of nonalcoholic steatohepatitis.
    Liou I, Kowdley KV.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and natural history of NAFLD and NASH.
    Ong JP, Younossi ZM.
    Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
    [Abstract] [Full Text] [Related]

  • 18. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT, de Oliveira CP, Corrêa-Giannella ML, Soares IC, Kubrusly MS, Bellodi-Privato M, de Mello ES, de Lima VM, Carrilho FJ, Alves VA.
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM, Gupte PA, de Vera ME, Ahmad J.
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [Abstract] [Full Text] [Related]

  • 20. Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis.
    Maeda T, Hashimoto K, Kihara Y, Ikegami T, Ishida T, Aimitsu S, Fujiwara M.
    Hepatogastroenterology; 2008 Jul; 55(85):1404-6. PubMed ID: 18795699
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.